(361.2) Levetiracetam as a Primary Agent

1. What is the mechanism of action of levetiracetam?
A. Binds and inhibits voltage-dependent Na+ channels
B. Binds to synaptic vesicle protein 2A
C. Binds and inhibits T-type Ca2+ channels
D. Binds to GABAA
E. None of the above
2. A common adverse effect of levetiracetam is:
A. Hypotension
B. Hepatotoxicity
C. Sedation
D. Eosinophilic pneumonitis
E. None of the above
3. When was levetiracetam FDA approved for the treatment of partial seizures in humans?
A. 1999
B. 2010
C. 1990
D. 2005
E. None of the above
4. Levetiracetam may be contraindicated in patients with:
A. Protein-losing enteropathy
B. Chronic kidney disease
C. Endocardiosis
D. Hepatic dysfunction
E. None of the above
5. Levetiracetam has high oral bioavailability with peak plasma concentrations occurring __________ after a single dose of the immediate release tablet?
A. 0.6 to 2.2 hours
B. 0.1 to 1 hour
C. 0.5 to 5 hours
D. 0.3 to 3 hours
E. None of the above
{"name":"(361.2) Levetiracetam as a Primary Agent", "url":"https://www.quiz-maker.com/QPREVIEW","txt":"1. What is the mechanism of action of levetiracetam?, 2. A common adverse effect of levetiracetam is:, 3. When was levetiracetam FDA approved for the treatment of partial seizures in humans?","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}

More Quizzes

Statitiska
528
GUJARATI GRAMMAR QUIZ NO 2
2512549
How well do you know your Falcons?
158502
English Thursday
14786
Which NCSSM Real N*gga Are You?
158251
Wicked
136109
The Insider Christmas quiz - Which Christmas song will you listen to at Christmas?
15852
Spanish Present Tense Conjugation
136331
Business Fundamentals Quiz
15848
Divine Feminine Energy Quiz
745
Kuka Variksista Olet?
14768
Κουίζ Ορθογραφίας
10513992
Powered by: Quiz Maker